# Rapport Therapeutics, Inc.: insider transactions

RAPP · Nasdaq · CIK 2012593 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rapp.md) · [Financials](/companies/rapp/financials.md) · [Filings](/companies/rapp/filings.md) · [Insiders](/companies/rapp/insiders.md)

## All transactions: 7

Non-derivative transactions reported on Forms 4, newest first. Codes P (purchase) and S (sale) are open-market trades. Reported price is as stated on the form, not a market price. Filter with ?type= `open-market`, `purchase`, `sale`.

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-23 | [Sanchez Ramiro](/insiders/1830326.md) | Director | Purchase (P) | 3,600 | $27.3549 | $98.5k | [Form 4](/filings/0001193125-26-430397.md) |
| 2026-10-22 | [Paul Steven M](/insiders/1237564.md) | Director | Purchase (P) | 35,714 | $27.28 | $974.3k | [Form 4](/filings/0001193125-26-429073.md) |
| 2026-10-22 | [Young Wendy B.](/insiders/2042847.md) | Director | Purchase (P) | 3,789 | $26.39 | $100.0k | [Form 4](/filings/0001193125-26-429074.md) |
| 2026-10-22 | [Silva Paul M](/insiders/1446372.md) | Director | Purchase (P) | 3,680 | $27.075 | $99.6k | [Form 4](/filings/0001193125-26-429075.md) |
| 2026-10-22 | [Maraganore John](/insiders/1180432.md) | Director | Purchase (P) | 1,172 | $26.9173 | $31.5k | [Form 4](/filings/0001193125-26-429071.md) |
| 2026-10-22 | [Maraganore John](/insiders/1180432.md) | Director | Purchase (P) | 8,239 | $26.3799 | $217.3k | [Form 4](/filings/0001193125-26-429071.md) |
| 2026-10-21 | [Ceesay Abraham](/insiders/1722140.md) | Chief Executive Officer, Director, Officer | Sale (S) | 2,210 | $29.1618 | $64.4k | [Form 4](/filings/0001193125-26-430504.md) |

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 30, 2026, 19:33 ET. No prices; not investment advice.